IP Library Granted Patent US 8,932,352
Granted Patent B2
US 8,932,352 · App. 13/686,952 · Granted Jan 13, 2015

Optical material and method for modifying the refractive index

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,932,352
App. No.
13/686,952
Granted
Jan 13, 2015
Kind
B2
Abstract

An optical device comprising an optical hydrogel with select regions that have been irradiated with laser light having a pulse energy from 0.01 nJ to 50 nJ and a wavelength from 600 nm to 900 nm. The irradiated regions are characterized by a positive change in refractive index of from 0.01 to 0.06, and exhibit little or no scattering loss. The optical hydrogel is prepared with a hydrophilic monomer.

Claims (16)

1. An optical device comprising an optical hydrogel with select regions that have been irradiated with laser light having a pulse energy from 0.01 nJ to 50 nJ and a wavelength from 600 nm to 900 nm, wherein the irradiated regions are characterized by a positive change in refractive index of from 0.01 to 0.06, and exhibit little or no scattering loss, and the optical hydrogel is prepared with a hydrophilic monomer.

2. The optical device of claim 1 wherein the irradiated region is an area or volume filled structure that is formed by scanning the laser light over the select regions of the optical hydrogel.

3. The optical device of claim 2 wherein the area or volume filled structure is defined by a series of line scans, the line scans having a width from 0.2 μm to 3 μm, and a height from 0.4 μm to 8 μm, wherein the height is measured in a Z-direction parallel to the laser light.

4. The optical device of claim 2 wherein the area or volume filled structure is a vertically stacked structure wherein the irradiated regions are formed separately in different planes in the hydrogel in a Z-direction parallel to the laser light.

5. The optical device of claim 1 wherein the optical hydrogel is prepared from (meth)acrylate monomer selected from the group consisting 2-phenylethyl(meth)acrylate, methyl(meth)acrylate and 3-phenylpropyl(meth)acrylate.

6. The optical device of claim 1 wherein the pulse energy of the laser light is from 0.2 nj to 10 nj.

7. The optical device of claim 1 wherein the laser generates light pulses having a pulse width of 4 fs to 100 fs.

8. The optical device of claim 1 wherein the hydrophilic monomer is selected from the group consisting of N-vinylpyrrolidone, 2-hydroxyethyl methacrylate, N,N-dimethylacrylamide and methacrylic acid.

9. The optical device of claim 1 wherein the optical hydrogel is prepared from a monomeric component present in the hydrogel in an amount of at least 70% by weight, and its homopolymer will have a refractive index of at least 1.50.

10. The optical device of claim 1 wherein the hydrogel is prepared with a crosslinking monomer, and the hydrogel will have a glass transition temperature not greater than 37° C. and an elongation of at least 150%.

11. The optical device of claim 1 selected from an intraocular lens, a corneal inlay, a corneal ring or a keratoprothesis.

12. The optical device of claim 11 is an intraocular lens that has been positioned in the eye of a patient.

13. The optical device of claim 11 is a corneal inlay that has been positioned in the eye of a patient.

14. An optical device comprising an optical polymeric material with select regions that have been irradiated with laser light having a pulse energy from 0.01 nJ to 50 nJ and a wavelength from 600 nm to 900 nm, wherein the irradiated regions are characterized by a positive change in refractive index of 0.01 or more and exhibit little or no scattering loss, and the optical polymeric material is prepared with a hydrophilic monomer.

15. The optical device of claim 14 selected from an intraocular lens, a corneal inlay, a corneal ring or a keratoprothesis.

16. The optical device of claim 14 wherein the hydrophilic monomer is selected from the group consisting of N-vinylpyrrolidone, 2-hydroxyethyl methacrylate, N,N-dimethylacrylamide, methacrylic acid, poly(ethylene glycol monomethacrylate), 1,4-butanediol monovinyl ether, 2-aminoethyl vinyl ether, di(ethylene glycol)monovinyl ether, ethylene glycol butyl vinyl ether, ethylene glycol monovinyl ether, glycidyl vinyl ether, glyceryl vinyl ether, vinyl carbonate, and vinyl carbamate.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS Recorded Feb 5, 2019
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 048259/0134 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2015
From: KUNZLER, JAY F.; JANI, DHARMENDRA; PINTO, CANDIDO D.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 035362/0805 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2015
From: KNOX, WAYNE H.; DING, LI
To: UNIVERSITY OF ROCHESTER
Reel/Frame 035362/0899 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME AND ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 033771 FRAME: 0019. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 22, 2014
From: KNOX, WAYNE
To: UNIVERSITY OF ROCHESTER
Reel/Frame 034032/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2014
From: DING, LI
To: UNIVERSITY OF ROCHESTER
Reel/Frame 033770/0556 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2014
From: KNOX, WAYNE
To: KNOX, WAYNE
Reel/Frame 033771/0019 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2014
From: KUNZLER, JAY FRIEDRICH; JANI, DHARMENDRA M.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 033771/0135 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2014
From: BAUSCH & LOMB INCORPORATED
To: UNIVERSITY OF ROCHESTER
Reel/Frame 033538/0812 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →